CIBC Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-357
Closed -$10K 1267
2022
Q3
$10K Hold
357
﹤0.01% 1244
2022
Q2
$15K Sell
357
-26
-7% -$1.76K ﹤0.01% 1263
2022
Q1
$39K Hold
383
﹤0.01% 1505
2021
Q4
$56K Buy
+383
New +$85.6K ﹤0.01% 1521

Other funds holding WGS

CIBC Asset Management's WGS Position: Q4 2022 in Review

CIBC Asset Management sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 357 shares — an estimated $10K sold.

CIBC Asset Management first reported a position in WGS in Q4 2021 and held it in 4 quarters. The position peaked at $56K in Q4 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

  • CIBC Asset Management reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
  • CIBC Asset Management sold 357 GeneDx Holdings shares in Q4 2022, an estimated $10K.
  • CIBC Asset Management first reported a position in GeneDx Holdings in Q4 2021 and held it in 4 quarters.
  • CIBC Asset Management's GeneDx Holdings position peaked at $56K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on CIBC Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.